
Algernon Health closes second tranche of financing
Algernon Health closes second tranche of financing

Algernon Health closes second tranche of financing
Algernon Closes Second Tranche of Private Placement Financing
Pharmacorp Rx Inc. Reports Q3 2025 Financial Results
Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials
Profound Medical to roll out Tulsa-AI BPH module
Hydreight closes acquisition of 5% of Perfect Scripts
Kane Biotech loses $607,345 in Q3 2025
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO(TM) Clinical Data, at RSNA and SUO Meetings
Kane Biotech Announces Third Quarter 2025 Financial Results
Principal Technologies arranges $2-million financing
Avricore's HealthTab supports inclisiran delivery
PRINCIPAL TECHNOLOGIES ANNOUNCES PRIVATE PLACEMENT FINANCING